Diurnal fluctuations in HPA and neuropeptide Y-ergic systems underlie differences in vulnerability to traumatic stress responses at different zeitgeber times

Neuropsychopharmacology

Volumn 40, Issue 3, 2015, Pages 774-790

  Cohen, Shlomi ^a   Vainer, Ella ^a   Matar, Michael A ^a   Kozlovsky, Nitsan ^a   Kaplan, Zeev ^a   Zohar, Joseph ^b   Mathé, Aleksander A ^c   Cohen, Hagit ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; DEXAMETHASONE; N2 DIPHENYLACETYL N (4 UREIDOMETHYLBENZYL)ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; ARGININE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y-Y1 RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BASOLATERAL AMYGDALA; BEHAVIORAL STRESS; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEXAMETHASONE SUPPRESSION TEST; ELEVATED PLUS MAZE TEST; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREACTIVITY; MALE; NEGATIVE FEEDBACK; NONHUMAN; PARAVENTRICULAR THALAMIC NUCLEUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOTRAUMA; RAT; STARTLE REFLEX; TIME; AMYGDALA; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; ENDOCRINE FUNCTION TEST; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRANASAL DRUG ADMINISTRATION; MAZE TEST; MENTAL STRESS; METABOLISM; MICROINJECTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; TIME FACTOR;

ADMINISTRATION, INTRANASAL; AMYGDALA; ANIMALS; ARCUATE NUCLEUS OF HYPOTHALAMUS; ARGININE; CIRCADIAN RHYTHM; CORTICOSTERONE; HIPPOCAMPUS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MAZE LEARNING; MICROINJECTIONS; NEUROPEPTIDE Y; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY-ADRENAL FUNCTION TESTS; PITUITARY-ADRENAL SYSTEM; PSYCHOLOGICAL TRAUMA; RATS; RECEPTORS, NEUROPEPTIDE Y; REFLEX, STARTLE; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 84922103772     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.257     Document Type: Article

References (75)

1. Ahima RS, Harlan RE (1990). Charting of type II glucocorticold receptor-like immunoreactivity in the rat central nervous system. Neuroscience 39: 579-604.
2. Akabayashi A, Watanabe Y, Wahlestedt C, McEwen BS, Paez X, Leibowitz SF (1994). Hypothalamic neuropeptide Y, its gene expression and receptor activity: relation to circulating corticosterone in adrenalectomized rats. Brain Res 665: 201-212.
3. Akana SF, Cascio CS, Du JZ, Levin N, Dallman MF (1986). Reset of feedback in the adrenocortical system: an apparent shift in sensitivity of adrenocorticotropin to inhibition by corticosterone between morning and evening. Endocrinology 119: 2325-2332.
4. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders. 4 edn American Psychiatric Association: Washington, DC.
5. Angelucci F, Aloe L, Jimenez-Vasquez P, Mathé AA (2002). Electroconvulsive stimuli alter the regional concentrations of nerve growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in adult rat brain. J Ect 18: 138-143.
6. Angelucci F, Aloe L, Jimenez-Vasquez P, Mathé AA (2003). Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell linederived neurotrophic factor in a rat model of depression. Int J Neuropsychopharmacol 6: 225-231.
7. Angelucci F, Aloe L, Vasquez PJ, Mathé AA (2000). Mapping the differences in the brain concentration of brainderived neurotrophic factor (BDNF) and nerve growth factor (NGF) in an animal model of depression. Neuroreport 11: 1369-1373.
8. Atkinson HC, Leggett JD, Wood SA, Castrique ES, Kershaw YM, Lightman SL (2010). Regulation of the hypothalamic-pituitaryadrenal axis circadian rhythm by endocannabinoids is sexually diergic. Endocrinology 151: 3720-3727.
9. Atkinson HC, Wood SA, Kershaw YM, Bate E, Lightman SL (2006). Diurnal variation in the responsiveness of the hypothalamicpituitary-adrenal axis of the male rat to noise stress. J Neuroendocrinol 18: 526-533.
10. Bai FL, Yamano M, Shiotani Y, Emson PC, Smith AD, Powell JF et al (1985). An arcuato-paraventricular and-dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. Brain Res 331: 172-175.
11. Bj-rnebekk A, Mathé A, Brené S (2010). The antidepressant effects of running and escitalopram are associated with levels of hippocampal NPY and Y1 receptor but not cell proliferation in a rat model of depression. Hippocampus 20: 820-828.
12. Brown HE, Garcia MM, Harlan RE (1998). A two focal plane method for digital quantification of nuclear immunoreactivity in large brain areas using NIH-image software. Brain Res Brain Res Protoc 2: 264-272.
13. Chabot CC, Taylor DH (1992a). Circadian modulation of the rat acoustic startle response. Behav Neurosci 106: 846-852.
14. Chabot CC, Taylor DH (1992b). Daily rhythmicity of the rat acoustic startle response. Physiol Behav 51: 885-889.
15. Choi S, Horsley C, Aguila S, Dallman MF (1996). The hypothalamic ventromedial nuclei couple activity in the hypothalamopituitary-adrenal axis to the morning fed or fasted state. J Neurosci 16: 8170-8180.
16. Cohen H, Joseph Z, Matar M (2003a). The relevance of differential response to trauma in an animal model of post-traumatic stress disorder. Biol Psychiatry 53: 463-473.
17. Cohen H, Liu T, Kozlovsky N, Kaplan Z, Zohar J, Mathe AA (2012). The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder. Neuropsychopharmacology 37: 350-363.
18. Cohen H, Matar MA, Buskila D, Kaplan Z, Zohar J (2008). Early post-stressor intervention with high dose corticosterone attenuates post traumatic stress response in an animal model of PTSD. Biol Psychiatry 64: 708-717.
19. Cohen H, Matar MA, Joseph Z (2013). Animal models of post-traumatic stress disorder. Curr Protoc Neurosci Chapter 9: Unit 9 45.
20. Cohen H, Zohar J (2004a). An animal model of posttraumatic stress disorder: the use of cut-off behavioral criteria. Ann NY Acad Sci 1032: 167-178.
21. Cohen H, Zohar J, Gidron Y, Matar MA, Belkind D, Loewenthal U et al (2006). Blunted HPA axis response to stress influences susceptibility to posttraumatic stress response in rats. Biol Psychiatry 59: 1208-1218.
22. Cohen H, Zohar J, Matar M (2003b). The relevance of differential response to trauma in an animal model of post-traumatic stress disorder. Biol Psychiatry 53: 463-473.
23. Cohen H, Zohar J, Matar M (2003c). The relevance of differential response to trauma in an animal model of posttraumatic stress disorder. Biol Psychiatry 53: 463-473.
24. Cohen H, Zohar J, Matar MA, Kaplan Z, Geva AB (2005a). Unsupervised fuzzy clustering analysis supports behavioral cutoff criteria in an animal model of posttraumatic stress disorder. Biol Psychiatry 58: 640-650.
25. Cohen H, Zohar J, Matar MA, Kaplan Z, Geva AB (2005b). Unsupervised fuzzy clustering analysis supports behavioral cutoff criteria in an animal model of posttraumatic stress disorder. Biol Psychiatry 58: 640-650.
26. Cohen H, Zohar J, Matar MA, Kaplan Z, Geva AB (2005c). Unsupervised fuzzy clustering analysis supports behavioral cutoff criteria in an animal model of posttraumatic stress disorder. Biol Psychiatry 58: 640-650.
27. Cohen H, Zohar J, Matar MA, Zeev K, Loewenthal U, Richter-Levin G (2004b). Setting apart the affected: the use of behavioral criteria in animal models of post traumatic stress disorder. Neuropsychopharmacology 29: 1962-1970.
28. Cohen H, Zohar J, Matar MA, Zeev K, Loewenthal U, Richter-Levin G (2004c). Setting apart the affected: the use of behavioral criteria in animal models of post traumatic stress disorder. Neuropsychopharmacology 29: 1962-1970.
29. Cole MA, Kim PJ, Kalman BA, Spencer RL (2000). Dexamethasone suppression of corticosteroid secretion: evaluation of the site of action by receptor measures and functional studies. Psychoneuroendocrinology 25: 151-167.
30. Daan S (2000). The Colin S. Pittendrigh Lecture. Colin Pittendrigh, Jurgen Aschoff, and the natural entrainment of circadian systems. J Biol Rhythms 15: 195-207.
31. Dallman M, Yates F (1969). Dynamic asymmetries in the corticosteroid feedback path and distribution-metabolism-binding elements of the adrenocortical system. Ann NY Acad Sci 156: 696-721.
32. Davis M, Sollberger A (1971). Twenty-four-hour periodicity of the startle response in rats. Psychonom Sci 25: 37-39.
33. de Quidt ME, Emson PC (1986). Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system-II. Immunohistochemical analysis. Neuroscience 18: 545-618.
34. Decressac M, Wright B, David B, Tyers P, Jaber M, Barker RA et al (2010). Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis. Hippocampus 21: 233-238.
35. Delahanty DL, Raimonde AJ, Spoonster E (2000). Initial posttraumatic urinary cortisol levels predict subsequent PTSD symptoms in motor vehicle accident victims. Biol Psychiatry 48: 940-947.
36. Domschke K, Dannlowski U, Hohoff C, Ohrmann P, Bauer J, Kugel H et al (2010). Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression. Eur Neuropsychopharmacol 20: 301-309.
37. File SE, Zangrossi H Jr, Sanders FL, Mabbutt PS (1993). Dissociation between behavioral and corticosterone responses on repeated exposures to cat odor. Physiol Behav 54: 1109-1111.
38. Fuxe K, Wikstrom A-C, Okret S, Agnati LF, Harfstrand A, Yu A-Y et al (1985). Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel-and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology 117: 1803-1812.
39. Hanson E, Dallman M (1995). Neuropeptide Y (NPY) may integrate responses of hypothalamic feeding systems and the hypothalamo-pituitary-adrenal axis. J Neuroendocrinol 7: 273-279.
40. Heilig M, Zachrisson O, Thorsell A, Ehnvall A, Mottagui-Tabar S, Sjogren M et al (2004). Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. J Psychiatr Res 38: 113-121.
41. Holmes MC, French KL, Seckl JR (1995). Modulation of serotonin and corticosteroid receptor gene expression in the rat hippocampus with circadian rhythm and stress. Brain Res Mol Brain Res 28: 186-192.
42. Howell OW, Silva S, Scharfman HE, Sosunov AA, Zaben M, Shatya A et al (2007). Neuropeptide Y is important for basal and seizure-induced precursor cell proliferation in the hippocampus. Neurobiol Dis 26: 174-188.
43. Husum H, Mathé A (2002). Early life stress changes concentrations of neuropeptide Y and corticotropin-releasing hormone in adult rat brain. Lithium treatment modifies these changes. Neuropsychopharmacology 27: 756-764.
44. Jhanwar-Uniyal M, Beck B, Burlet C, Leibowitz SF (1990). Diurnal rhythm of neuropeptide Y-like immunoreactivity in the suprachiasmatic, arcuate and paraventricular nuclei and other hypothalamic sites. Brain Res 536: 331-334.
45. Jiménez-Vasquez P, Diaz-Cabiale Z, Caberlotto L, Bellido I, Overstreet D, Fuxe K et al (2007). Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression. Eur Neuropsychopharmacol 17: 298-308.
46. Kalsbeek A, Ruiter M, La Fleur SE, Van Heijningen C, Buijs RM (2003). The diurnal modulation of hormonal responses in the rat varies with different stimuli. J Neuroendocrinol 15: 1144-1155.
47. Kask A, Harro J, von Horsten S, Redrobe JP, Dumont Y, Quirion R (2002). The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev 26: 259-283.
48. Lightman SL, Windle RJ, Julian MD, Harbuz MS, Shanks N, Wood SA et al (2000). Significance of pulsatility in the HPA axis. Novartis Found Symp 227: 244-257 discussion 257-260.
49. Lilly MP, Jones RO, Putney DJ, Carlson DE (2000). Post-surgical recovery and time-of-day mask potentiated responses of ACTH to repeated moderate hemorrhage in conscious rats. J Endocrinol 167: 205-217.
50. Mathe A (1999). Neuropeptides and electroconvulsive treatment. J Ect 15: 60-75.
51. Mathe A, Rudorfer M, Stenfors C, Manji H, Potter W, Theodorsson E (1996). Effects of electroconvulsive treatment on somatostatin, neuropeptide Y, endothelin and neurokinin A concentration in cerebrospinal fluid of depressed patients. Depression 3: 250-257.
52. Mathias S, Schiffelholz T, Linthorst AC, Pollmacher T, Lancel M (2000). Diurnal variations in lipopolysaccharide-induced sleep, sickness behavior and changes in corticosterone levels in the rat. Neuroendocrinology 71: 375-385.
53. Mathé A, Husum H, El Khoury A, Jiménez-Vasquez P, Gruber S, Wörtwein G et al (2007). Search for biological correlates of depression and mechanisms of action of antidepressant treatment modalities. Do neuropeptides play a role? Physiol Behav 92: 226-231.
54. McEwen BS (2002). The neurobiology and neuroendocrinology of stress. Implications for post-traumatic stress disorder from a basic science perspective. Psychiatr Clin North Am 25: 469-494.
55. McFarlane AC, Atchison M, Yehuda R (1997). The acute stress response following motor vehicle accidents and its relation to PTSD. Ann N Y Acad Sci 821: 437-441.
56. McFarlane S (2000). Dendritic morphogenesis: building an arbor. Mol Neurobiol 22: 1-9.
57. McKibbin PE, Rogers P, Williams G (1991). Increased neuropeptide Y concentrations in the lateral hypothalamic area of the rat after the onset of darkness: possible relevance to the circadian periodicity of feeding behavior. Life Sci 48: 2527-2533.
58. Neumann ID, Wegener G, Homberg JR, Cohen H, Slattery DA, Zohar J et al (2011). Animal models of depression and anxiety: What do they tell us about human condition? Prog Neuropsychopharmacol Biol Psychiatry 35: 1357-1375.
59. Paxinos G, Watson C (1988). The Rat Brain in Stereotaxic Coordinates London.
60. Redrobe JP, Dumont Y, St-Pierre JA, Quirion R (1999). Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition. Brain Res 848: 153-166.
61. Retana-Marquez S, Bonilla-Jaime H, Vazquez-Palacios G, Dominguez-Salazar E, Martinez-Garcia R, Velazquez-Moctezuma J (2003). Body weight gain and diurnal differences of corticosterone changes in response to acute and chronic stress in rats. Psychoneuroendocrinology 28: 207-227.
62. Rivier CL, Plotsky PM (1986). Mediation by corticotropin releasing factor (CRF) of adenohypophysial hormone secretion. Ann Rec Physiol 48: 475-494.
63. Sajdyk TJ, Johnson PL, Leitermann RJ, Fitz SD, Dietrich A, Morin M et al (2008). Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia. J Neurosci 28: 893-903.
64. Sawchenko PE, Swanson LW, Grzanna R, Howe PR, Bloom SR, Polak JM (1985). Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 241: 138-153.
65. Serova LI, Tillinger A, Alaluf LG, Laukova M, Keegan K, Sabban EL (2013). Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats. Neuroscience 236: 298-312.
66. Torrellas A, Guaza C, Borrell J, Borrell S (1981). Adrenal hormones and brain catecholamines responses to morning and afternoon immobilization stress in rats. Physiol Behav 26: 129-133.
67. van Dijk G, Strubbe JH (2003). Time-dependent effects of neuropeptide Y infusion in the paraventricular hypothalamus on ingestive and associated behaviors in rats. Physiol Behav 79: 575-580.
68. Wahlestedt C, Skagerberg G, Ekman R, Heilig M, Sundler F, Hakanson R (1987). Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitaryadrenocortical axis in the rat. Brain Res 417: 33-38.
69. Wieland HA, Engel W, Eberlein W, Rudolf K, Doods HN (1998). Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents. Br J Pharmacol 125: 549-555.
70. Windle RJ, Wood SA, Shanks N, Lightman SL, Ingram CD (1998). Ultradian rhythm of basal corticosterone release in the female rat: dynamic interaction with the response to acute stress. Endocrinology 139: 443-450.
71. Witteveen AB, Huizink AC, Slottje P, Bramsen I, Smid T, van der Ploeg HM (2010). Associations of cortisol with posttraumatic stress symptoms and negative life events: a study of police officers and firefighters. Psychoneuroendocrinology 35: 1113-1118.
72. Wu G, Feder A, Wegener G, Bailey C, Saxena S, Charney D et al (2011). Central functions of neuropeptide Y in mood and anxiety disorders. Expert Opin Ther Targets 15: 1317-1331.
73. Xavier LL, Viola GG, Ferraz AC, Da Cunha C, Deonizio JM, Netto CA et al (2005). A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area. Brain Res Brain Res Protoc 16: 58-64.
74. Yannielli PC, Harrington ME (2001). Neuropeptide Y in the mammalian circadian system: effects on light-induced circadian responses. Peptides 22: 547-556.
75. Yehuda R, McFarlane AC, Shalev AY (1998). Predicting the development of posttraumatic stress disorder from the acute response to a traumatic event. Biol Psychiatry 44: 1305-1313.